Citadel Advisors »

Enveric Biosciences shares owned by Citadel Advisors

Quarter-by-quarter ownership of Enveric Biosciences (ENVB) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Enveric Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Enveric Biosciences held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enveric Biosciences by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $6.0k 13k 0.47
2024-03-31 $40k 40k 1.00
2023-06-30 $47k 14k 3.37

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Booking Holdings Call Option (BKNG)
Spdr Gold Tr Gold Shs Call Option (GLD)

View all positions for Citadel Advisors

Top funds holding Enveric Biosciences

AdvisorShares Investments
Geode Capital Management
BlackRock
Virtu Financial
Vanguard Group
Two Sigma Securities
Citadel Advisors
Tower Research Capital
BlackRock
Advisor Group Holdings
Group One Trading
Bank of America Corporation
National Bank Of Canada /fi/
Nelson, Van Denburg & Campbell Wealth Management
Wells Fargo & Company

View all funds holding Enveric Biosciences